INTERNATIONAL PATENT: PRILENIA THERAPEUTICS INC. FILES APPLICATION FOR "PRIDOPIDINE FOR THE TREATMENT OF DISTAL HEREDITARY MOTOR NEUROPATHY (DHMN)"

GENEVA, April 20 -- PRILENIA THERAPEUTICS INC. (300 Fifth Avenue, Suite 5010Waltham, Massachusetts 02451) filed a patent application (PCT/US2025/050160) for "PRIDOPIDINE FOR THE TREATMENT OF DISTAL HEREDITARY MOTOR NEUROPATHY (DHMN)" on Oct 09, 2025. With publication no. WO/2026/080658, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HAYDEN, Michael (c/o Prilenia Therapeutics Inc.300 Fifth Avenue, Suite 5010Waltham, New York 02451), GEVA, Michal (c/o Prilenia Therapeutics Inc.300 Fifth Avenue, Suite 5010Waltham, New York ...